These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 33524788)
1. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways. Dou Y; Huang R; Li Q; Liu Y; Li Y; Chen H; Ai G; Xie J; Zeng H; Chen J; Luo C; Su Z Biomed Pharmacother; 2021 May; 137():111312. PubMed ID: 33524788 [TBL] [Abstract][Full Text] [Related]
2. Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo. Li CL; Tan LH; Wang YF; Luo CD; Chen HB; Lu Q; Li YC; Yang XB; Chen JN; Liu YH; Xie JH; Su ZR Phytomedicine; 2019 Jan; 52():272-283. PubMed ID: 30599908 [TBL] [Abstract][Full Text] [Related]
3. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway. Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats. Li QP; Dou YX; Huang ZW; Chen HB; Li YC; Chen JN; Liu YH; Huang XQ; Zeng HF; Yang XB; Su ZR; Xie JH Phytomedicine; 2021 May; 85():153550. PubMed ID: 33831691 [TBL] [Abstract][Full Text] [Related]
5. Intestines-erythrocytes-mediated bio-disposition deciphers the hypolipidemic effect of berberine from Rhizoma Coptidis: A neglected insight. Huang Z; Li M; Qin Z; Ma X; Huang R; Liu Y; Xie J; Zeng H; Zhan R; Su Z J Ethnopharmacol; 2023 Oct; 314():116600. PubMed ID: 37196811 [TBL] [Abstract][Full Text] [Related]
6. Oxyberberine ameliorates TNBS-induced colitis in rats through suppressing inflammation and oxidative stress via Keap1/Nrf2/NF-κB signaling pathways. Li C; Liu M; Deng L; Luo D; Ma R; Lu Q Phytomedicine; 2023 Jul; 116():154899. PubMed ID: 37247589 [TBL] [Abstract][Full Text] [Related]
7. Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats. Chen K; Li G; Geng F; Zhang Z; Li J; Yang M; Dong L; Gao F Apoptosis; 2014 Jun; 19(6):946-57. PubMed ID: 24664781 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo hypoglycemia effect of oxyberberine, a novel HO-1 agonist: A renewed evidence linking HO-1 to diabetes mellitus. Dou Y; Ai G; Huang R; Huang Z; Li Y; Liu Y; Xie J; Chen J; Su Z Phytomedicine; 2022 Jul; 101():154135. PubMed ID: 35509133 [TBL] [Abstract][Full Text] [Related]
9. Anti-Inflammatory Activation of Phellodendri Chinensis Cortex is Mediated by Berberine Erythrocytes Self-Assembly Targeted Delivery System. Li M; Qin Z; Yu Q; Huang Z; Cheng J; Zhong L; Liu Y; Xie J; Li Y; Chen J; Zhan R; Su Z Drug Des Devel Ther; 2022; 16():4365-4383. PubMed ID: 36583113 [TBL] [Abstract][Full Text] [Related]
10. A comparative investigation of the interaction and pharmacokinetics of hemoglobin with berberine and its oxymetabolite. Chen HB; Luo CD; Ai GX; Wang YF; Li CL; Tan LH; Lee SM; Cheung AK; Su ZR; Wu XL; Xie JH; Zeng HF J Pharm Biomed Anal; 2021 May; 199():114032. PubMed ID: 33774454 [TBL] [Abstract][Full Text] [Related]
11. Protective Effects of Oxyberberine in 5-Fluorouracil-Induced Intestinal Mucositis in the Mice Model. Huang R; Ai G; Zhong L; Mai L; Chen JN; Liu Y; Li Y; Huang X; Su Z; Zhan JY Evid Based Complement Alternat Med; 2022; 2022():1238358. PubMed ID: 35677366 [TBL] [Abstract][Full Text] [Related]
12. Berberine alleviates fructose-induced hepatic injury via ADK/AMPK/Nrf2 pathway: A novel insight. Cheng J; Yan G; Tan W; Qin Z; Xie Q; Liu Y; Li Y; Chen J; Yang X; Chen J; Su Z; Xie J Biomed Pharmacother; 2024 Oct; 179():117361. PubMed ID: 39243432 [TBL] [Abstract][Full Text] [Related]
13. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling. Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433 [TBL] [Abstract][Full Text] [Related]
14. Berberine promotes peri-implant osteogenesis in diabetic rats by ROS-mediated IRS-1 pathway. Shao J; Liu S; Zheng X; Chen J; Li L; Zhu Z Biofactors; 2021 Jan; 47(1):80-92. PubMed ID: 33233028 [TBL] [Abstract][Full Text] [Related]
15. Berberine activates Nrf2 nuclear translocation and inhibits apoptosis induced by high glucose in renal tubular epithelial cells through a phosphatidylinositol 3-kinase/Akt-dependent mechanism. Zhang X; Liang D; Lian X; Jiang Y; He H; Liang W; Zhao Y; Chi ZH Apoptosis; 2016 Jun; 21(6):721-36. PubMed ID: 26979714 [TBL] [Abstract][Full Text] [Related]
17. Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress. Cui HX; Hu YN; Li JW; Yuan K Oxid Med Cell Longev; 2018; 2018():8930374. PubMed ID: 30662584 [TBL] [Abstract][Full Text] [Related]
18. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids. Yao Y; Chen H; Yan L; Wang W; Wang D Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246 [TBL] [Abstract][Full Text] [Related]
19. Antidiabetic effects of pterostilbene through PI3K/Akt signal pathway in high fat diet and STZ-induced diabetic rats. Sun H; Liu X; Long SR; Teng Wang ; Ge H; Wang Y; Yu S; Xue Y; Zhang Y; Li X; Li W Eur J Pharmacol; 2019 Sep; 859():172526. PubMed ID: 31283935 [TBL] [Abstract][Full Text] [Related]
20. Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like cells. Hsu YY; Chen CS; Wu SN; Jong YJ; Lo YC Eur J Pharm Sci; 2012 Aug; 46(5):415-25. PubMed ID: 22469516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]